Mayumi Nagashimada

Kanazawa, 9208640, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Cenicriviroc Suppresses and Reverses Steatohepatitis by Regulating Macrophage Infiltration and M2 Polarization in Mice.

Cenicriviroc Suppresses and Reverses Steatohepatitis by Regulating Macrophage Infiltration and M2 Polarization in Mice.

Journal: Endocrinology

Published: November 20, 2023

A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation.

A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation.

Journal: Diabetology international

Published: May 16, 2023

CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status.

CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status.

Journal: Metabolism: clinical and experimental

Published: April 21, 2022

CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice.

CC chemokine ligand 3 deficiency ameliorates diet-induced steatohepatitis by regulating liver macrophage recruitment and M1/M2 status in mice.

Journal: Metabolism: clinical and experimental

Published: July 14, 2021

Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics.

Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics.

Journal: International journal of molecular sciences

Published: June 02, 2021

Enhanced enteric neurogenesis by Schwann cell precursors in mouse models of Hirschsprung disease.

Enhanced enteric neurogenesis by Schwann cell precursors in mouse models of Hirschsprung disease.

Journal: Glia

Published: December 15, 2020

CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice.

CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice.

Journal: Endocrinology

Published: December 02, 2020

Lactobacillus pentosus strain S-PT84 improves steatohepatitis by maintaining gut permeability.

Lactobacillus pentosus strain S-PT84 improves steatohepatitis by maintaining gut permeability.

Journal: The Journal of endocrinology

Published: July 29, 2020

LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH.

LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH.

Journal: Scientific reports

Published: May 15, 2020

DPP-4 Inhibition with Anagliptin Reduces Lipotoxicity-Induced Insulin Resistance and Steatohepatitis in Male Mice.

DPP-4 Inhibition with Anagliptin Reduces Lipotoxicity-Induced Insulin Resistance and Steatohepatitis in Male Mice.

Journal: Endocrinology

Published: April 21, 2020

Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice.

Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice.

Journal: Free radical biology & medicine

Published: September 27, 2019

Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.

Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet.

Journal: BMJ open diabetes research & care

Published: August 01, 2019

Showing 1-12 of 32

Last Updated: 09/26/2026